Multiple Myeloma Stories: Relapsed/Refractory MM Patient Shares Daratumumab, Elotuzimab Experience

Clay dives in-depth into his relapsed/refractory multiple myeloma story. In this video conversation with The Patient Story founder, Stephanie, he shares his most recent treatment experiences since his first interview two years ago (FULL STORY/TRANSCRIPT HERE: https://www.thepatientstory.com/cancers/multiple-myeloma/active-myeloma/clay-drake)

Newest therapies/regimen:
– Daratumumab (Darzalex) monthly
– Elotuzimab (Empliciti) bi-monthly
– IVIg infusions, Intravenous immunoglobulin (IVIg)
– Lenalidomide (Revlimid) 28 days a month

Clay also talks about powering through years worth of treatments, managing his mental and physical health, and his thoughts on the current treatment options for RR multiple myeloma.